Boyu Capital is a private equity firm that invests in consumer, retail, media and technology, healthcare, and financial services sectors.
Business Model: B2C
Revenue: $5M
Employees: 11-50
Address: 88 Queensway
City: Hong Kong
State: other
Zip:
Country: HK
Boyu Capital Consultancy Co. Ltd is a private equity firm specializing in investments in China. Boyu Capital Consultancy Co. Ltd was founded on September 28, 2010 and is based in Hong Kong with an additional office in Beijing, China.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2021 | XSKY Data Technology | Series E | 0 |
9/2018 | LianLian Pay | Venture Round | 146.6M |
8/2021 | Pulse Medical Technology | Series C | 0 |
5/2022 | Shuaike Pet Food Products | Private Equity Round | 0 |
3/2022 | MoreSec | Series D | 0 |
1/2021 | KLOOK | Series E | 0 |
9/2017 | LifeMine Therapeutics | Series A | 0 |
6/2021 | RecBio | Series C | 156.3M |
9/2019 | Chengjia Apartment | Series A | 300M |
12/2020 | SciNeuro | Series A | 100M |
11/2017 | Berry Oncology | Series A | 121.2M |
4/2021 | J&a;T Express | Private Equity Round | 2B |
5/2013 | Berry Genomics | Series B | 14.7M |
5/2018 | China Chengxin Credit | Series A | 0 |
8/2021 | MediTrust Health | Series C | 0 |
10/2021 | WT Microtech Medical | Series E | 153M |
5/2018 | Brii Biosciences | Venture Round | 260M |
1/2019 | Yimidida | Series D | 266.1M |
3/2020 | Yuanfudao | Series G | 1B |
3/2020 | Pinduoduo | Post-IPO Equity | 1.1B |
6/2019 | Waterdrop | Series C | 144.6M |
4/2021 | Adcentrx Therapeutics | Series A | 50M |
9/2022 | Animoca Brands | Convertible Note | 110M |
9/2012 | Alibaba Group | Private Equity Round | 0 |
5/2018 | CStone Pharmaceuticals | Series B | 260M |
11/2021 | Positive Sequence Biology | Series A | 0 |
3/2020 | Yatsen Holding | Series D | 240M |
6/2022 | Frontera Therapeutics | Series B | 0 |
1/2021 | 4Paradigm | Series D | 0 |
11/2021 | Edge Medical Robotics | Series C | 0 |
1/2021 | Lalamove | Series F | 1.5B |
1/2019 | Antengene Corporation | Series B | 0 |
8/2021 | Abogen Biosciences | Series C | 0 |
6/2021 | ArriVent Biopharma | Series A | 81M |
2/2022 | ArriVent Biopharma | Series A | 69M |
6/2014 | COFCO | Post-IPO Equity | - |
12/2022 | ArriVent Biopharma | Series B | 0 |
11/2020 | D3 Bio | Series A | 200M |
12/2021 | Jinke | Post-IPO Equity | 478.6M |
2/2014 | LY.com | Series C | 82.3M |
6/2022 | Evat Master | Series A | 0 |
8/2018 | KLOOK | Series D | 200M |
7/2016 | CStone Pharmaceuticals | Series A | 150M |
12/2021 | Recurrent.ai | Venture Round | 38M |
7/2020 | Antengene Corporation | Series C | 97M |
8/2021 | MediTrust Health | Series C | 308.3M |
12/2019 | Kuaishou Technology | Series F | 3B |
11/2018 | NetEase Cloud Music | Series B | 600M |
2/2018 | Viela Bio | Series A | 0 |
7/2018 | Trax | Series D | 0 |
11/2021 | Vision Medicals | Series D | 47M |
11/2021 | J&a;T Express | Private Equity Round | 0 |
8/2020 | Yuanfudao | Series G | 1.2B |
8/2021 | Zeekr | Series A | 500M |
2/2017 | iQiyi | Series G | 1.5B |
7/2018 | MEGVII | Series D | - |
7/2018 | Curon Biopharma | Series A | 150M |
6/2022 | Frontera Therapeutics | Series B | 0 |
6/2022 | Evat Master | Series A | 0 |
5/2022 | Shuaike Pet Food Products | Private Equity Round | 0 |
3/2022 | MoreSec | Series D | 0 |
2/2022 | ArriVent Biopharma | Series A | 0 |
12/2021 | Recurrent.ai | Venture Round | 0 |
12/2021 | Jinke | Post-IPO Equity | 0 |
11/2021 | Vision Medicals | Series D | 0 |
11/2021 | J&a;T Express | Private Equity Round | 0 |
11/2021 | Positive Sequence Biology | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|